全球角膜移植市场

预计到 2030 年全球角膜移植市场规模将达到 5.771 亿美元

2024 年全球角膜移植市场规模估计为 4.552 亿美元，预计到 2030 年将达到 5.771 亿美元，在 2024-2030 年分析期内的复合年增长率为 4.0%。穿透性角膜移植术是报告中分析的细分领域之一，预计复合年增长率为 5.7%，到分析期结束时将达到 1.803 亿美元。在分析期内，内皮角膜移植部分的成长率估计为 2.6%。

美国市场规模估计为 1.24 亿美元，中国市场预计复合年增长率为 7.7%

预计2024年美国角膜移植市值将达1.24亿美元。作为世界第二大经济体的中国，预计2030年市场规模将达到1.193亿美元，2024-2030年分析期间的复合年增长率为7.7%。其他值得注意的区域市场包括日本和加拿大，预计在分析期间的复合年增长率分别为 1.5% 和 3.2%。在欧洲，德国的复合年增长率预计为 2.3%。

全球角膜移植市场－主要趋势与驱动因素摘要

为什么角膜移植在全球的临床和研究领域重新兴起？

角膜移植可以为患有角膜混浊、营养不良、退化性或感染性角膜病变的患者恢復视力，是世界上最成功和最常见的器官移植手术之一。随着全球因老化、外伤和感染疾病导致的角膜失明盛行率不断上升，对有效、便利、可重复的角膜移植手术的需求也在稳步增长。对于许多患者，特别是低收入和服务不足社区的患者来说，角膜移植是避免终身视力障碍或失明的唯一治疗方法。

手术技术、组织保存技术和捐赠者筛检通讯协定的进步正在重新定义角膜移植的安全性和有效性。临床偏好从全层穿透性角膜移植术 (PK) 转向选择性板层移植技术，例如 Descemet 膜剥离自动化内皮角膜移植术 (DSAEK) 和 Descemet 膜内皮角膜移植术 (DMEK)，改善了治疗结果并缩短了恢復时间。这种手术转型得益于诊断、手术设备和外科医生培训基础设施的改进，特别是世界各地的眼科卓越中心。

哪些技术和临床进步将影响角膜移植的未来？

在捐赠组织的处理和手术精确度方面，重大技术创新正在进行中。眼库正在采用先进的组织准备技术，例如预切和预剥离移植物，以减少术中变异性并提高移植的一致性。低温和器官培养保存技术可以实现捐赠组织的长期储存和国际运输，有助于弥补地理上的供应差距。

飞秒雷射辅助角膜移植术透过实现超精确的钻孔和无缝线伤口构建，彻底改变了移植界面品质。同时，术中 OCT（光同调断层扫瞄）越来越多地被用于即时视觉化移植物-宿主排列和液体界面，特别是在内皮手术中。组织黏合剂、显微注射输送工具和微创切口技术进一步加快了术后恢復并减少了併发症。

新的前沿包括使用合成角膜植入、生物工程支架和异质骨移植，这些技术正在无法获得或不适合人类捐赠组织的患者中进行试验。研究人员也正在探索细胞治疗方法（例如培养内皮细胞注射）对内皮功能障碍的作用，有可能完全消除对完整移植的需求。人工智慧正被用于供体-受体匹配演算法、术后监测以及基于多参数输入的移植物存活率预测。

谁是主要相关人员以及地理趋势如何影响采用？

角膜移植生态系统的主要相关人员包括眼科医师、眼库、医院移植计画、非营利眼科照护基金会和国家器官捐赠网络。在美国、德国、日本和澳洲等新兴市场，捐赠角膜的取得受到良好的监管，并得到强而有力的报销制度和集中眼库服务的支持。这些国家正在迅速转向内皮角膜移植手术，这种手术可以提供更好的视力恢復、更低的排斥率和更少的手术创伤。

相较之下，亚洲、非洲和拉丁美洲的新兴国家面临捐赠者短缺、眼库基础设施不发达和手术能力有限的挑战。儘管角膜失明的负担很重，印度还是透过全国范围的眼角膜捐赠宣传活动以及透过公私合营模式扩大社区眼库取得了进展。撒哈拉以南非洲和东南亚国家也正在采用远距眼科和移动角膜筛检单位，以便及时识别和转诊移植候选人。

由世卫组织、国际奥比斯组织和各国政府部门主导的全球眼保健倡议正在努力提高服务欠缺地区的意识、培训和资源配置。此外，世界各地的学术中心和移植协会之间的合作正在创建知识共用平台，以促进技能发展、标准化和跨境创新传播。

是什么推动了角膜移植市场的加速成长？

角膜移植市场的成长受到医疗需求、技术成熟度和捐赠组织物流系统改进等多种因素的推动。圆锥角膜、福克斯角膜内皮营养不良症以及因外伤导致的角膜损伤的增多，对手术的需求持续增加。同时，选择性板层移植的成功降低了併发症的发生率，使更多的患者能够接受该手术。

改进的法律规范，包括标准化的组织安全测试和储存指南，导致国际组织共用生态系统不断发展。报销政策，尤其是在新兴市场，正在推动先进手术方案和技术的采用。同时，全球医疗保健组织正在投资能力建设项目，以培训外科医生、扩大手术推广并加强眼角膜捐赠管道。

合成角膜和生物工程角膜替代品的创新为克服对捐赠者的依赖提供了长期潜力，特别是在面临持续短缺的地区。随着个人化医疗和再生疗法的进步，市场细分正在从独立的外科手术领域发展成为全球眼科护理领域的综合性、技术主导领域，确保持续成长并扩大治疗效益。

部分

手术类型（穿透性角膜移植、内皮角膜移植、Desmet 剥离自动内皮角膜移植、角膜移植、角膜缘干细胞移植、其他手术）；适应症（真菌性角膜溃疡、水痘角膜病变、圆锥角膜、角膜炎、其他适应症）；最终用户（医院、眼科诊所、其他最终用户）

受访公司范例（44家值得关注的公司）

• AJL Ophthalmic SA
• Alcon, Inc.
• Aurolab
• CorneaGen
• CorNeat Vision Ltd.
• CryoLife, Inc.
• DIOPTEX GmbH
• ExaTech, Inc.
• EyeYon Medical Ltd.
• Florida Lions Eye Bank
• KeraMed, Inc.
• Kohler GmbH
• LifeCell
• Lifeline Scientific Inc.
• LinkoCare Life Sciences AB
• Massachusetts Eye and Ear
• Medtronic
• Presbia PLC
• San Diego Eye Bank

关税影响係数

全球产业分析师根据公司总部所在国家、製造地以及进出口（成品和OEM）预测公司竞争地位的变化。这种复杂且多方面的市场动态预计将以多种方式影响竞争对手，包括人为提高销货成本、降低盈利、重组供应链等微观和宏观市场动态。

全球产业分析师密切关注世界领先的首席经济学家（14,949）、智库（62）和贸易及产业协会（171）的专家意见，以评估生态系统的影响并应对新的市场现实。各主要国家的专家和经济学家都在关注关税及其对国家的影响。

全球产业分析师预计，这种动盪将在未来两到三个月内平息，新的世界秩序将更加明确地建立。全球产业分析师正在即时追踪这些发展。

2025年4月：谈判阶段

我们四月份的发布将涵盖关税对全球市场整体的影响，并为各地区的市场调整提供指导。我们的预测是基于历史数据和不断发展的市场影响因素。

2025年7月：最终关税调整

免费更新 在各国宣布最终重置后，本公司的客户将在 7 月收到免费更新。最终更新包含明确的关税影响分析。

相互和双边贸易及关税影响分析：

美国<>中国<>墨西哥<>加拿大<>欧盟<>日本<>印度<>其他176个国家

领先的产业经济学家：全球产业分析师知识库追踪 14,949 位经济学家，其中包括来自民族国家、智库、贸易和产业协会、大型企业和领域专家的最具影响力的首席经济学家，他们共用了全球经济状况这一前所未有的模式转移的影响。我们的 16,491 多份报告中的大多数都遵循这个基于两阶段里程碑的发布计划。

目录

第一章调查方法

第二章执行摘要

• 市场概览
• 主要企业
• 市场趋势和驱动因素
• 全球市场展望

第三章市场分析

• 美国
• 加拿大
• 日本
• 中国
• 欧洲
• 法国
• 德国
• 义大利
• 英国
• 西班牙
• 俄罗斯
• 其他欧洲国家
• 亚太地区
• 澳洲
• 印度
• 韩国
• 其他亚太地区
• 拉丁美洲
• 阿根廷
• 巴西
• 墨西哥
• 其他拉丁美洲
• 中东
• 伊朗
• 以色列
• 沙乌地阿拉伯
• 阿拉伯聯合大公国
• 其他中东地区
• 非洲

第四章 比赛

Global Corneal Transplants Market to Reach US$577.1 Million by 2030

The global market for Corneal Transplants estimated at US$455.2 Million in the year 2024, is expected to reach US$577.1 Million by 2030, growing at a CAGR of 4.0% over the analysis period 2024-2030. Penetrating Keratoplasty Procedure, one of the segments analyzed in the report, is expected to record a 5.7% CAGR and reach US$180.3 Million by the end of the analysis period. Growth in the Endothelial Keratoplasty Procedure segment is estimated at 2.6% CAGR over the analysis period.

The U.S. Market is Estimated at US$124.0 Million While China is Forecast to Grow at 7.7% CAGR

The Corneal Transplants market in the U.S. is estimated at US$124.0 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$119.3 Million by the year 2030 trailing a CAGR of 7.7% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 1.5% and 3.2% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 2.3% CAGR.

Global Corneal Transplants Market - Key Trends & Drivers Summarized

Why Are Corneal Transplants Gaining Renewed Clinical and Research Momentum Globally?

Corneal transplants remain one of the most successful and commonly performed organ transplant procedures worldwide, offering restorative vision to patients affected by corneal opacities, dystrophies, and degenerative or infectious keratopathies. As global prevalence of corneal blindness increases-driven by aging populations, trauma, and infectious diseases-the demand for effective, accessible, and repeatable corneal grafting procedures is steadily growing. For many patients, especially in lower-income or underserved regions, corneal transplantation represents the only curative solution to avoid lifelong visual impairment or blindness.

Advancements in surgical techniques, tissue preservation technologies, and donor screening protocols are redefining the safety and efficacy of corneal transplants. Shifting clinical preferences from full-thickness penetrating keratoplasty (PK) toward selective lamellar procedures-such as Descemet stripping automated endothelial keratoplasty (DSAEK) and Descemet membrane endothelial keratoplasty (DMEK)-are improving outcomes and recovery times. This surgical transition is supported by improved diagnostics, surgical instrumentation, and surgeon training infrastructure, particularly in ophthalmology centers of excellence across the globe.

What Technological and Clinical Advancements Are Shaping the Future of Corneal Grafting?

Significant innovation is underway in both donor tissue handling and surgical precision. Eye banks are adopting advanced tissue preparation techniques-such as pre-cut and pre-stripped grafts-that reduce intraoperative variability and improve transplant consistency. Hypothermic and organ culture preservation methods are enabling longer storage and international shipment of donor tissue, helping to bridge geographic disparities in availability.

Femtosecond laser-assisted keratoplasty is revolutionizing graft interface quality by enabling ultra-precise trephination and sutureless wound construction. Meanwhile, intraoperative OCT (optical coherence tomography) is being increasingly used for real-time visualization of graft-host alignment and fluid interface, especially in endothelial procedures. Tissue adhesives, micro-injection delivery tools, and less invasive incision techniques are further accelerating postoperative recovery and minimizing complications.

Emerging frontiers include the use of synthetic corneal implants, bioengineered scaffolds, and xenografts, which are being trialed in patients for whom human donor tissue is unavailable or unsuitable. Researchers are also exploring the role of cell-based therapies-such as cultured endothelial cell injections-for endothelial dysfunctions, potentially eliminating the need for full grafts altogether. Artificial intelligence is being leveraged for donor-recipient matching algorithms, postoperative monitoring, and predicting graft survival based on multi-parametric inputs.

Who Are the Major Stakeholders and How Are Geographic Trends Influencing Adoption?

The key stakeholders in the corneal transplant ecosystem include ophthalmic surgeons, eye banks, hospital-based transplant programs, non-profit eye health foundations, and national organ donation networks. In developed markets such as the U.S., Germany, Japan, and Australia, access to donor corneas is well-regulated and supported by robust reimbursement systems and centralized eye banking services. These countries are witnessing a rapid shift toward endothelial keratoplasty techniques that offer better visual recovery, lower rejection rates, and reduced surgical trauma.

In contrast, emerging economies in Asia, Africa, and Latin America face challenges related to donor scarcity, underdeveloped eye banking infrastructure, and limited surgical capacity. India, despite a high burden of corneal blindness, has made strides through national eye donation campaigns and the expansion of regional eye banks under public-private partnership models. Countries in Sub-Saharan Africa and Southeast Asia are also adopting teleophthalmology and mobile corneal screening units to facilitate timely identification and referral of transplant candidates.

International eye health initiatives-spearheaded by WHO, Orbis International, and national ministries-are working to improve awareness, training, and resource allocation in underserved regions. Additionally, global collaborations between academic centers and transplant societies are creating knowledge-sharing platforms that drive skill development, standardization, and innovation diffusion across borders.

What Is Driving the Accelerated Growth in the Corneal Transplants Market?

The growth in the corneal transplants market is driven by a combination of medical need, technological maturity, and systemic improvements in donor tissue logistics. Rising incidence of keratoconus, Fuchs endothelial dystrophy, and trauma-related corneal damage is generating consistent procedural demand. At the same time, the success of selective lamellar grafting techniques is reducing complication rates and making surgery accessible to broader patient cohorts.

Improved regulatory frameworks, such as the standardization of tissue safety testing and preservation guidelines, are expanding the international tissue-sharing ecosystem. Reimbursement policies, especially in developed markets, are supporting the adoption of advanced surgical options and technologies. In parallel, global health organizations are investing in capacity-building programs to train surgeons, expand surgical outreach, and enhance the eye donation pipeline.

Innovation in synthetic and bioengineered corneal substitutes offers long-term potential to overcome donor dependency, particularly in regions facing persistent shortages. As personalized medicine and regenerative therapies progress, the corneal transplants market is evolving from an episodic surgical discipline into an integrated, technology-driven segment of global ophthalmic care-ensuring its sustained growth and expanding therapeutic impact.

SCOPE OF STUDY:

The report analyzes the Corneal Transplants market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Procedure Type (Penetrating Keratoplasty, Endothelial Keratoplasty, Descemet Stripping Automated Endothelial Keratoplasty, Corneal Grafts, Corneal Limbal Stem Cell Transplants, Other Procedures); Indication (Fungal Corneal Ulcer, Bullous Keratopathy, Keratoconus, Keratitis, Other Indications); End-Use (Hospitals, Eye Clinics, Other End-Uses)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 44 Featured) -

• AJL Ophthalmic SA
• Alcon, Inc.
• Aurolab
• CorneaGen
• CorNeat Vision Ltd.
• CryoLife, Inc.
• DIOPTEX GmbH
• ExaTech, Inc.
• EyeYon Medical Ltd.
• Florida Lions Eye Bank
• KeraMed, Inc.
• Kohler GmbH
• LifeCell
• Lifeline Scientific Inc.
• LinkoCare Life Sciences AB
• Massachusetts Eye and Ear
• Medtronic
• Presbia PLC
• San Diego Eye Bank

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by artificially increasing the COGS, reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

We are diligently following expert opinions of leading Chief Economists (14,949), Think Tanks (62), Trade & Industry bodies (171) worldwide, as they assess impact and address new market realities for their ecosystems. Experts and economists from every major country are tracked for their opinions on tariffs and how they will impact their countries.

We expect this chaos to play out over the next 2-3 months and a new world order is established with more clarity. We are tracking these developments on a real time basis.

As we release this report, U.S. Trade Representatives are pushing their counterparts in 183 countries for an early closure to bilateral tariff negotiations. Most of the major trading partners also have initiated trade agreements with other key trading nations, outside of those in the works with the United States. We are tracking such secondary fallouts as supply chains shift.

To our valued clients, we say, we have your back. We will present a simplified market reassessment by incorporating these changes!

APRIL 2025: NEGOTIATION PHASE

Our April release addresses the impact of tariffs on the overall global market and presents market adjustments by geography. Our trajectories are based on historic data and evolving market impacting factors.

JULY 2025 FINAL TARIFF RESET

Complimentary Update: Our clients will also receive a complimentary update in July after a final reset is announced between nations. The final updated version incorporates clearly defined Tariff Impact Analyses.

Reciprocal and Bilateral Trade & Tariff Impact Analyses:

USA <> CHINA <> MEXICO <> CANADA <> EU <> JAPAN <> INDIA <> 176 OTHER COUNTRIES.

Leading Economists - Our knowledge base tracks 14,949 economists including a select group of most influential Chief Economists of nations, think tanks, trade and industry bodies, big enterprises, and domain experts who are sharing views on the fallout of this unprecedented paradigm shift in the global econometric landscape. Most of our 16,491+ reports have incorporated this two-stage release schedule based on milestones.

COMPLIMENTARY PREVIEW

Contact your sales agent to request an online 300+ page complimentary preview of this research project. Our preview will present full stack sources, and validated domain expert data transcripts. Deep dive into our interactive data-driven online platform.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

• 1. MARKET OVERVIEW
  • Influencer Market Insights
  • World Market Trajectories
  • Impact of Covid-19 and a Looming Global Recession
  • Corneal Transplants - Global Key Competitors Percentage Market Share in 2025 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
• 2. FOCUS ON SELECT PLAYERS
• 3. MARKET TRENDS & DRIVERS
  • Rising Prevalence of Corneal Blindness and Degenerative Eye Conditions Drives Demand for Corneal Transplants
  • Expansion of Eye Banking and Donor Tissue Availability Throws the Spotlight on Surgical Accessibility
  • Growth in Femtosecond Laser and Lamellar Keratoplasty Techniques Enhances Transplant Precision
  • OEM Innovation in DMEK and DSAEK Surgical Tools Strengthens Minimally Invasive Transplant Outcomes
  • Increased Success Rates and Visual Recovery Accelerate Surgeon and Patient Acceptance
  • Surge in Aging Population and Diabetes-Related Eye Disorders Supports Global Market Expansion
  • Focus on Artificial Corneas and Bioengineered Grafts Drives Research in Synthetic Alternatives
  • Regulatory Approvals of Eye Tissue Preservation and Transport Solutions Enhance Logistics
  • OEM Investment in Custom-Fit and Preloaded Graft Kits Improves Surgical Workflow and Efficiency
  • Growth in Global Outreach and Mission-Based Eye Surgeries Expands Access in Low-Income Regions
  • OEM Partnerships With Eye Banks and NGOs Support Tissue Donation Infrastructure
  • Adoption of Corneal Cross-Linking in Early-Stage Keratoconus Delays Need for Full-Thickness Transplants
  • OEM Development of Training Simulators and Virtual Surgery Tools Enhances Surgeon Skills
  • Expansion of Private Eye Care Centers in Emerging Markets Supports Elective Procedure Growth
  • Integration of Tele-Ophthalmology in Referral Networks Streamlines Patient Evaluation for Transplant
  • OEM Focus on Low-Rejection Tissue Typing and Immunosuppression Protocols Improves Graft Longevity
  • Use of AI in Pre-Surgical Mapping and Post-Transplant Monitoring Enhances Clinical Decision-Making
  • Global Efforts to Reduce Transplant Waiting Lists Sustain Policy-Level Support
  • Focus on Bilateral Disease Treatment and Cosmetic Restoration Expands Surgical Demand Beyond Function
• 4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: World Corneal Transplants Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
  • TABLE 2: World Recent Past, Current & Future Analysis for Corneal Transplants by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 3: World Historic Review for Corneal Transplants by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 4: World 15-Year Perspective for Corneal Transplants by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
  • TABLE 5: World Recent Past, Current & Future Analysis for Penetrating Keratoplasty by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 6: World Historic Review for Penetrating Keratoplasty by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 7: World 15-Year Perspective for Penetrating Keratoplasty by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 8: World Recent Past, Current & Future Analysis for Endothelial Keratoplasty by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 9: World Historic Review for Endothelial Keratoplasty by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 10: World 15-Year Perspective for Endothelial Keratoplasty by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 11: World Recent Past, Current & Future Analysis for Descemet Stripping Automated Endothelial Keratoplasty by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 12: World Historic Review for Descemet Stripping Automated Endothelial Keratoplasty by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 13: World 15-Year Perspective for Descemet Stripping Automated Endothelial Keratoplasty by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 14: World Recent Past, Current & Future Analysis for Corneal Grafts by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 15: World Historic Review for Corneal Grafts by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 16: World 15-Year Perspective for Corneal Grafts by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 17: World Recent Past, Current & Future Analysis for Corneal Limbal Stem Cell Transplants by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 18: World Historic Review for Corneal Limbal Stem Cell Transplants by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 19: World 15-Year Perspective for Corneal Limbal Stem Cell Transplants by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 20: World Recent Past, Current & Future Analysis for Other Procedures by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 21: World Historic Review for Other Procedures by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 22: World 15-Year Perspective for Other Procedures by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 23: World Recent Past, Current & Future Analysis for Keratitis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 24: World Historic Review for Keratitis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 25: World 15-Year Perspective for Keratitis by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 26: World Recent Past, Current & Future Analysis for Other Indications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 27: World Historic Review for Other Indications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 28: World 15-Year Perspective for Other Indications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 29: World Recent Past, Current & Future Analysis for Fungal Corneal Ulcer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 30: World Historic Review for Fungal Corneal Ulcer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 31: World 15-Year Perspective for Fungal Corneal Ulcer by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 32: World Recent Past, Current & Future Analysis for Bullous Keratopathy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 33: World Historic Review for Bullous Keratopathy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 34: World 15-Year Perspective for Bullous Keratopathy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 35: World Recent Past, Current & Future Analysis for Keratoconus by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 36: World Historic Review for Keratoconus by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 37: World 15-Year Perspective for Keratoconus by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 38: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 39: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 40: World 15-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 41: World Recent Past, Current & Future Analysis for Eye Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 42: World Historic Review for Eye Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 43: World 15-Year Perspective for Eye Clinics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 44: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 45: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 46: World 15-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

• UNITED STATES
  • Corneal Transplants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
  • TABLE 47: USA Recent Past, Current & Future Analysis for Corneal Transplants by Procedure Type - Penetrating Keratoplasty, Endothelial Keratoplasty, Descemet Stripping Automated Endothelial Keratoplasty, Corneal Grafts, Corneal Limbal Stem Cell Transplants and Other Procedures - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 48: USA Historic Review for Corneal Transplants by Procedure Type - Penetrating Keratoplasty, Endothelial Keratoplasty, Descemet Stripping Automated Endothelial Keratoplasty, Corneal Grafts, Corneal Limbal Stem Cell Transplants and Other Procedures Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 49: USA 15-Year Perspective for Corneal Transplants by Procedure Type - Percentage Breakdown of Value Sales for Penetrating Keratoplasty, Endothelial Keratoplasty, Descemet Stripping Automated Endothelial Keratoplasty, Corneal Grafts, Corneal Limbal Stem Cell Transplants and Other Procedures for the Years 2015, 2025 & 2030
  • TABLE 50: USA Recent Past, Current & Future Analysis for Corneal Transplants by Indication - Keratitis, Other Indications, Fungal Corneal Ulcer, Bullous Keratopathy and Keratoconus - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 51: USA Historic Review for Corneal Transplants by Indication - Keratitis, Other Indications, Fungal Corneal Ulcer, Bullous Keratopathy and Keratoconus Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 52: USA 15-Year Perspective for Corneal Transplants by Indication - Percentage Breakdown of Value Sales for Keratitis, Other Indications, Fungal Corneal Ulcer, Bullous Keratopathy and Keratoconus for the Years 2015, 2025 & 2030
  • TABLE 53: USA Recent Past, Current & Future Analysis for Corneal Transplants by End-Use - Hospitals, Eye Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 54: USA Historic Review for Corneal Transplants by End-Use - Hospitals, Eye Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 55: USA 15-Year Perspective for Corneal Transplants by End-Use - Percentage Breakdown of Value Sales for Hospitals, Eye Clinics and Other End-Uses for the Years 2015, 2025 & 2030
• CANADA
  • TABLE 56: Canada Recent Past, Current & Future Analysis for Corneal Transplants by Procedure Type - Penetrating Keratoplasty, Endothelial Keratoplasty, Descemet Stripping Automated Endothelial Keratoplasty, Corneal Grafts, Corneal Limbal Stem Cell Transplants and Other Procedures - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 57: Canada Historic Review for Corneal Transplants by Procedure Type - Penetrating Keratoplasty, Endothelial Keratoplasty, Descemet Stripping Automated Endothelial Keratoplasty, Corneal Grafts, Corneal Limbal Stem Cell Transplants and Other Procedures Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 58: Canada 15-Year Perspective for Corneal Transplants by Procedure Type - Percentage Breakdown of Value Sales for Penetrating Keratoplasty, Endothelial Keratoplasty, Descemet Stripping Automated Endothelial Keratoplasty, Corneal Grafts, Corneal Limbal Stem Cell Transplants and Other Procedures for the Years 2015, 2025 & 2030
  • TABLE 59: Canada Recent Past, Current & Future Analysis for Corneal Transplants by Indication - Keratitis, Other Indications, Fungal Corneal Ulcer, Bullous Keratopathy and Keratoconus - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 60: Canada Historic Review for Corneal Transplants by Indication - Keratitis, Other Indications, Fungal Corneal Ulcer, Bullous Keratopathy and Keratoconus Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 61: Canada 15-Year Perspective for Corneal Transplants by Indication - Percentage Breakdown of Value Sales for Keratitis, Other Indications, Fungal Corneal Ulcer, Bullous Keratopathy and Keratoconus for the Years 2015, 2025 & 2030
  • TABLE 62: Canada Recent Past, Current & Future Analysis for Corneal Transplants by End-Use - Hospitals, Eye Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 63: Canada Historic Review for Corneal Transplants by End-Use - Hospitals, Eye Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 64: Canada 15-Year Perspective for Corneal Transplants by End-Use - Percentage Breakdown of Value Sales for Hospitals, Eye Clinics and Other End-Uses for the Years 2015, 2025 & 2030
• JAPAN
  • Corneal Transplants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
  • TABLE 65: Japan Recent Past, Current & Future Analysis for Corneal Transplants by Procedure Type - Penetrating Keratoplasty, Endothelial Keratoplasty, Descemet Stripping Automated Endothelial Keratoplasty, Corneal Grafts, Corneal Limbal Stem Cell Transplants and Other Procedures - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 66: Japan Historic Review for Corneal Transplants by Procedure Type - Penetrating Keratoplasty, Endothelial Keratoplasty, Descemet Stripping Automated Endothelial Keratoplasty, Corneal Grafts, Corneal Limbal Stem Cell Transplants and Other Procedures Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 67: Japan 15-Year Perspective for Corneal Transplants by Procedure Type - Percentage Breakdown of Value Sales for Penetrating Keratoplasty, Endothelial Keratoplasty, Descemet Stripping Automated Endothelial Keratoplasty, Corneal Grafts, Corneal Limbal Stem Cell Transplants and Other Procedures for the Years 2015, 2025 & 2030
  • TABLE 68: Japan Recent Past, Current & Future Analysis for Corneal Transplants by Indication - Keratitis, Other Indications, Fungal Corneal Ulcer, Bullous Keratopathy and Keratoconus - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 69: Japan Historic Review for Corneal Transplants by Indication - Keratitis, Other Indications, Fungal Corneal Ulcer, Bullous Keratopathy and Keratoconus Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 70: Japan 15-Year Perspective for Corneal Transplants by Indication - Percentage Breakdown of Value Sales for Keratitis, Other Indications, Fungal Corneal Ulcer, Bullous Keratopathy and Keratoconus for the Years 2015, 2025 & 2030
  • TABLE 71: Japan Recent Past, Current & Future Analysis for Corneal Transplants by End-Use - Hospitals, Eye Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 72: Japan Historic Review for Corneal Transplants by End-Use - Hospitals, Eye Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 73: Japan 15-Year Perspective for Corneal Transplants by End-Use - Percentage Breakdown of Value Sales for Hospitals, Eye Clinics and Other End-Uses for the Years 2015, 2025 & 2030
• CHINA
  • Corneal Transplants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
  • TABLE 74: China Recent Past, Current & Future Analysis for Corneal Transplants by Procedure Type - Penetrating Keratoplasty, Endothelial Keratoplasty, Descemet Stripping Automated Endothelial Keratoplasty, Corneal Grafts, Corneal Limbal Stem Cell Transplants and Other Procedures - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 75: China Historic Review for Corneal Transplants by Procedure Type - Penetrating Keratoplasty, Endothelial Keratoplasty, Descemet Stripping Automated Endothelial Keratoplasty, Corneal Grafts, Corneal Limbal Stem Cell Transplants and Other Procedures Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 76: China 15-Year Perspective for Corneal Transplants by Procedure Type - Percentage Breakdown of Value Sales for Penetrating Keratoplasty, Endothelial Keratoplasty, Descemet Stripping Automated Endothelial Keratoplasty, Corneal Grafts, Corneal Limbal Stem Cell Transplants and Other Procedures for the Years 2015, 2025 & 2030
  • TABLE 77: China Recent Past, Current & Future Analysis for Corneal Transplants by Indication - Keratitis, Other Indications, Fungal Corneal Ulcer, Bullous Keratopathy and Keratoconus - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 78: China Historic Review for Corneal Transplants by Indication - Keratitis, Other Indications, Fungal Corneal Ulcer, Bullous Keratopathy and Keratoconus Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 79: China 15-Year Perspective for Corneal Transplants by Indication - Percentage Breakdown of Value Sales for Keratitis, Other Indications, Fungal Corneal Ulcer, Bullous Keratopathy and Keratoconus for the Years 2015, 2025 & 2030
  • TABLE 80: China Recent Past, Current & Future Analysis for Corneal Transplants by End-Use - Hospitals, Eye Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 81: China Historic Review for Corneal Transplants by End-Use - Hospitals, Eye Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 82: China 15-Year Perspective for Corneal Transplants by End-Use - Percentage Breakdown of Value Sales for Hospitals, Eye Clinics and Other End-Uses for the Years 2015, 2025 & 2030
• EUROPE
  • Corneal Transplants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
  • TABLE 83: Europe Recent Past, Current & Future Analysis for Corneal Transplants by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 84: Europe Historic Review for Corneal Transplants by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 85: Europe 15-Year Perspective for Corneal Transplants by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
  • TABLE 86: Europe Recent Past, Current & Future Analysis for Corneal Transplants by Procedure Type - Penetrating Keratoplasty, Endothelial Keratoplasty, Descemet Stripping Automated Endothelial Keratoplasty, Corneal Grafts, Corneal Limbal Stem Cell Transplants and Other Procedures - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 87: Europe Historic Review for Corneal Transplants by Procedure Type - Penetrating Keratoplasty, Endothelial Keratoplasty, Descemet Stripping Automated Endothelial Keratoplasty, Corneal Grafts, Corneal Limbal Stem Cell Transplants and Other Procedures Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 88: Europe 15-Year Perspective for Corneal Transplants by Procedure Type - Percentage Breakdown of Value Sales for Penetrating Keratoplasty, Endothelial Keratoplasty, Descemet Stripping Automated Endothelial Keratoplasty, Corneal Grafts, Corneal Limbal Stem Cell Transplants and Other Procedures for the Years 2015, 2025 & 2030
  • TABLE 89: Europe Recent Past, Current & Future Analysis for Corneal Transplants by Indication - Keratitis, Other Indications, Fungal Corneal Ulcer, Bullous Keratopathy and Keratoconus - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 90: Europe Historic Review for Corneal Transplants by Indication - Keratitis, Other Indications, Fungal Corneal Ulcer, Bullous Keratopathy and Keratoconus Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 91: Europe 15-Year Perspective for Corneal Transplants by Indication - Percentage Breakdown of Value Sales for Keratitis, Other Indications, Fungal Corneal Ulcer, Bullous Keratopathy and Keratoconus for the Years 2015, 2025 & 2030
  • TABLE 92: Europe Recent Past, Current & Future Analysis for Corneal Transplants by End-Use - Hospitals, Eye Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 93: Europe Historic Review for Corneal Transplants by End-Use - Hospitals, Eye Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 94: Europe 15-Year Perspective for Corneal Transplants by End-Use - Percentage Breakdown of Value Sales for Hospitals, Eye Clinics and Other End-Uses for the Years 2015, 2025 & 2030
• FRANCE
  • Corneal Transplants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
  • TABLE 95: France Recent Past, Current & Future Analysis for Corneal Transplants by Procedure Type - Penetrating Keratoplasty, Endothelial Keratoplasty, Descemet Stripping Automated Endothelial Keratoplasty, Corneal Grafts, Corneal Limbal Stem Cell Transplants and Other Procedures - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 96: France Historic Review for Corneal Transplants by Procedure Type - Penetrating Keratoplasty, Endothelial Keratoplasty, Descemet Stripping Automated Endothelial Keratoplasty, Corneal Grafts, Corneal Limbal Stem Cell Transplants and Other Procedures Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 97: France 15-Year Perspective for Corneal Transplants by Procedure Type - Percentage Breakdown of Value Sales for Penetrating Keratoplasty, Endothelial Keratoplasty, Descemet Stripping Automated Endothelial Keratoplasty, Corneal Grafts, Corneal Limbal Stem Cell Transplants and Other Procedures for the Years 2015, 2025 & 2030
  • TABLE 98: France Recent Past, Current & Future Analysis for Corneal Transplants by Indication - Keratitis, Other Indications, Fungal Corneal Ulcer, Bullous Keratopathy and Keratoconus - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 99: France Historic Review for Corneal Transplants by Indication - Keratitis, Other Indications, Fungal Corneal Ulcer, Bullous Keratopathy and Keratoconus Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 100: France 15-Year Perspective for Corneal Transplants by Indication - Percentage Breakdown of Value Sales for Keratitis, Other Indications, Fungal Corneal Ulcer, Bullous Keratopathy and Keratoconus for the Years 2015, 2025 & 2030
  • TABLE 101: France Recent Past, Current & Future Analysis for Corneal Transplants by End-Use - Hospitals, Eye Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 102: France Historic Review for Corneal Transplants by End-Use - Hospitals, Eye Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 103: France 15-Year Perspective for Corneal Transplants by End-Use - Percentage Breakdown of Value Sales for Hospitals, Eye Clinics and Other End-Uses for the Years 2015, 2025 & 2030
• GERMANY
  • Corneal Transplants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
  • TABLE 104: Germany Recent Past, Current & Future Analysis for Corneal Transplants by Procedure Type - Penetrating Keratoplasty, Endothelial Keratoplasty, Descemet Stripping Automated Endothelial Keratoplasty, Corneal Grafts, Corneal Limbal Stem Cell Transplants and Other Procedures - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 105: Germany Historic Review for Corneal Transplants by Procedure Type - Penetrating Keratoplasty, Endothelial Keratoplasty, Descemet Stripping Automated Endothelial Keratoplasty, Corneal Grafts, Corneal Limbal Stem Cell Transplants and Other Procedures Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 106: Germany 15-Year Perspective for Corneal Transplants by Procedure Type - Percentage Breakdown of Value Sales for Penetrating Keratoplasty, Endothelial Keratoplasty, Descemet Stripping Automated Endothelial Keratoplasty, Corneal Grafts, Corneal Limbal Stem Cell Transplants and Other Procedures for the Years 2015, 2025 & 2030
  • TABLE 107: Germany Recent Past, Current & Future Analysis for Corneal Transplants by Indication - Keratitis, Other Indications, Fungal Corneal Ulcer, Bullous Keratopathy and Keratoconus - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 108: Germany Historic Review for Corneal Transplants by Indication - Keratitis, Other Indications, Fungal Corneal Ulcer, Bullous Keratopathy and Keratoconus Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 109: Germany 15-Year Perspective for Corneal Transplants by Indication - Percentage Breakdown of Value Sales for Keratitis, Other Indications, Fungal Corneal Ulcer, Bullous Keratopathy and Keratoconus for the Years 2015, 2025 & 2030
  • TABLE 110: Germany Recent Past, Current & Future Analysis for Corneal Transplants by End-Use - Hospitals, Eye Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 111: Germany Historic Review for Corneal Transplants by End-Use - Hospitals, Eye Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 112: Germany 15-Year Perspective for Corneal Transplants by End-Use - Percentage Breakdown of Value Sales for Hospitals, Eye Clinics and Other End-Uses for the Years 2015, 2025 & 2030
• ITALY
  • TABLE 113: Italy Recent Past, Current & Future Analysis for Corneal Transplants by Procedure Type - Penetrating Keratoplasty, Endothelial Keratoplasty, Descemet Stripping Automated Endothelial Keratoplasty, Corneal Grafts, Corneal Limbal Stem Cell Transplants and Other Procedures - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 114: Italy Historic Review for Corneal Transplants by Procedure Type - Penetrating Keratoplasty, Endothelial Keratoplasty, Descemet Stripping Automated Endothelial Keratoplasty, Corneal Grafts, Corneal Limbal Stem Cell Transplants and Other Procedures Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 115: Italy 15-Year Perspective for Corneal Transplants by Procedure Type - Percentage Breakdown of Value Sales for Penetrating Keratoplasty, Endothelial Keratoplasty, Descemet Stripping Automated Endothelial Keratoplasty, Corneal Grafts, Corneal Limbal Stem Cell Transplants and Other Procedures for the Years 2015, 2025 & 2030
  • TABLE 116: Italy Recent Past, Current & Future Analysis for Corneal Transplants by Indication - Keratitis, Other Indications, Fungal Corneal Ulcer, Bullous Keratopathy and Keratoconus - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 117: Italy Historic Review for Corneal Transplants by Indication - Keratitis, Other Indications, Fungal Corneal Ulcer, Bullous Keratopathy and Keratoconus Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 118: Italy 15-Year Perspective for Corneal Transplants by Indication - Percentage Breakdown of Value Sales for Keratitis, Other Indications, Fungal Corneal Ulcer, Bullous Keratopathy and Keratoconus for the Years 2015, 2025 & 2030
  • TABLE 119: Italy Recent Past, Current & Future Analysis for Corneal Transplants by End-Use - Hospitals, Eye Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 120: Italy Historic Review for Corneal Transplants by End-Use - Hospitals, Eye Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 121: Italy 15-Year Perspective for Corneal Transplants by End-Use - Percentage Breakdown of Value Sales for Hospitals, Eye Clinics and Other End-Uses for the Years 2015, 2025 & 2030
• UNITED KINGDOM
  • Corneal Transplants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
  • TABLE 122: UK Recent Past, Current & Future Analysis for Corneal Transplants by Procedure Type - Penetrating Keratoplasty, Endothelial Keratoplasty, Descemet Stripping Automated Endothelial Keratoplasty, Corneal Grafts, Corneal Limbal Stem Cell Transplants and Other Procedures - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 123: UK Historic Review for Corneal Transplants by Procedure Type - Penetrating Keratoplasty, Endothelial Keratoplasty, Descemet Stripping Automated Endothelial Keratoplasty, Corneal Grafts, Corneal Limbal Stem Cell Transplants and Other Procedures Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 124: UK 15-Year Perspective for Corneal Transplants by Procedure Type - Percentage Breakdown of Value Sales for Penetrating Keratoplasty, Endothelial Keratoplasty, Descemet Stripping Automated Endothelial Keratoplasty, Corneal Grafts, Corneal Limbal Stem Cell Transplants and Other Procedures for the Years 2015, 2025 & 2030
  • TABLE 125: UK Recent Past, Current & Future Analysis for Corneal Transplants by Indication - Keratitis, Other Indications, Fungal Corneal Ulcer, Bullous Keratopathy and Keratoconus - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 126: UK Historic Review for Corneal Transplants by Indication - Keratitis, Other Indications, Fungal Corneal Ulcer, Bullous Keratopathy and Keratoconus Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 127: UK 15-Year Perspective for Corneal Transplants by Indication - Percentage Breakdown of Value Sales for Keratitis, Other Indications, Fungal Corneal Ulcer, Bullous Keratopathy and Keratoconus for the Years 2015, 2025 & 2030
  • TABLE 128: UK Recent Past, Current & Future Analysis for Corneal Transplants by End-Use - Hospitals, Eye Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 129: UK Historic Review for Corneal Transplants by End-Use - Hospitals, Eye Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 130: UK 15-Year Perspective for Corneal Transplants by End-Use - Percentage Breakdown of Value Sales for Hospitals, Eye Clinics and Other End-Uses for the Years 2015, 2025 & 2030
• SPAIN
  • TABLE 131: Spain Recent Past, Current & Future Analysis for Corneal Transplants by Procedure Type - Penetrating Keratoplasty, Endothelial Keratoplasty, Descemet Stripping Automated Endothelial Keratoplasty, Corneal Grafts, Corneal Limbal Stem Cell Transplants and Other Procedures - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 132: Spain Historic Review for Corneal Transplants by Procedure Type - Penetrating Keratoplasty, Endothelial Keratoplasty, Descemet Stripping Automated Endothelial Keratoplasty, Corneal Grafts, Corneal Limbal Stem Cell Transplants and Other Procedures Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 133: Spain 15-Year Perspective for Corneal Transplants by Procedure Type - Percentage Breakdown of Value Sales for Penetrating Keratoplasty, Endothelial Keratoplasty, Descemet Stripping Automated Endothelial Keratoplasty, Corneal Grafts, Corneal Limbal Stem Cell Transplants and Other Procedures for the Years 2015, 2025 & 2030
  • TABLE 134: Spain Recent Past, Current & Future Analysis for Corneal Transplants by Indication - Keratitis, Other Indications, Fungal Corneal Ulcer, Bullous Keratopathy and Keratoconus - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 135: Spain Historic Review for Corneal Transplants by Indication - Keratitis, Other Indications, Fungal Corneal Ulcer, Bullous Keratopathy and Keratoconus Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 136: Spain 15-Year Perspective for Corneal Transplants by Indication - Percentage Breakdown of Value Sales for Keratitis, Other Indications, Fungal Corneal Ulcer, Bullous Keratopathy and Keratoconus for the Years 2015, 2025 & 2030
  • TABLE 137: Spain Recent Past, Current & Future Analysis for Corneal Transplants by End-Use - Hospitals, Eye Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 138: Spain Historic Review for Corneal Transplants by End-Use - Hospitals, Eye Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 139: Spain 15-Year Perspective for Corneal Transplants by End-Use - Percentage Breakdown of Value Sales for Hospitals, Eye Clinics and Other End-Uses for the Years 2015, 2025 & 2030
• RUSSIA
  • TABLE 140: Russia Recent Past, Current & Future Analysis for Corneal Transplants by Procedure Type - Penetrating Keratoplasty, Endothelial Keratoplasty, Descemet Stripping Automated Endothelial Keratoplasty, Corneal Grafts, Corneal Limbal Stem Cell Transplants and Other Procedures - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 141: Russia Historic Review for Corneal Transplants by Procedure Type - Penetrating Keratoplasty, Endothelial Keratoplasty, Descemet Stripping Automated Endothelial Keratoplasty, Corneal Grafts, Corneal Limbal Stem Cell Transplants and Other Procedures Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 142: Russia 15-Year Perspective for Corneal Transplants by Procedure Type - Percentage Breakdown of Value Sales for Penetrating Keratoplasty, Endothelial Keratoplasty, Descemet Stripping Automated Endothelial Keratoplasty, Corneal Grafts, Corneal Limbal Stem Cell Transplants and Other Procedures for the Years 2015, 2025 & 2030
  • TABLE 143: Russia Recent Past, Current & Future Analysis for Corneal Transplants by Indication - Keratitis, Other Indications, Fungal Corneal Ulcer, Bullous Keratopathy and Keratoconus - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 144: Russia Historic Review for Corneal Transplants by Indication - Keratitis, Other Indications, Fungal Corneal Ulcer, Bullous Keratopathy and Keratoconus Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 145: Russia 15-Year Perspective for Corneal Transplants by Indication - Percentage Breakdown of Value Sales for Keratitis, Other Indications, Fungal Corneal Ulcer, Bullous Keratopathy and Keratoconus for the Years 2015, 2025 & 2030
  • TABLE 146: Russia Recent Past, Current & Future Analysis for Corneal Transplants by End-Use - Hospitals, Eye Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 147: Russia Historic Review for Corneal Transplants by End-Use - Hospitals, Eye Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 148: Russia 15-Year Perspective for Corneal Transplants by End-Use - Percentage Breakdown of Value Sales for Hospitals, Eye Clinics and Other End-Uses for the Years 2015, 2025 & 2030
• REST OF EUROPE
  • TABLE 149: Rest of Europe Recent Past, Current & Future Analysis for Corneal Transplants by Procedure Type - Penetrating Keratoplasty, Endothelial Keratoplasty, Descemet Stripping Automated Endothelial Keratoplasty, Corneal Grafts, Corneal Limbal Stem Cell Transplants and Other Procedures - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 150: Rest of Europe Historic Review for Corneal Transplants by Procedure Type - Penetrating Keratoplasty, Endothelial Keratoplasty, Descemet Stripping Automated Endothelial Keratoplasty, Corneal Grafts, Corneal Limbal Stem Cell Transplants and Other Procedures Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 151: Rest of Europe 15-Year Perspective for Corneal Transplants by Procedure Type - Percentage Breakdown of Value Sales for Penetrating Keratoplasty, Endothelial Keratoplasty, Descemet Stripping Automated Endothelial Keratoplasty, Corneal Grafts, Corneal Limbal Stem Cell Transplants and Other Procedures for the Years 2015, 2025 & 2030
  • TABLE 152: Rest of Europe Recent Past, Current & Future Analysis for Corneal Transplants by Indication - Keratitis, Other Indications, Fungal Corneal Ulcer, Bullous Keratopathy and Keratoconus - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 153: Rest of Europe Historic Review for Corneal Transplants by Indication - Keratitis, Other Indications, Fungal Corneal Ulcer, Bullous Keratopathy and Keratoconus Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 154: Rest of Europe 15-Year Perspective for Corneal Transplants by Indication - Percentage Breakdown of Value Sales for Keratitis, Other Indications, Fungal Corneal Ulcer, Bullous Keratopathy and Keratoconus for the Years 2015, 2025 & 2030
  • TABLE 155: Rest of Europe Recent Past, Current & Future Analysis for Corneal Transplants by End-Use - Hospitals, Eye Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 156: Rest of Europe Historic Review for Corneal Transplants by End-Use - Hospitals, Eye Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 157: Rest of Europe 15-Year Perspective for Corneal Transplants by End-Use - Percentage Breakdown of Value Sales for Hospitals, Eye Clinics and Other End-Uses for the Years 2015, 2025 & 2030
• ASIA-PACIFIC
  • Corneal Transplants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
  • TABLE 158: Asia-Pacific Recent Past, Current & Future Analysis for Corneal Transplants by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 159: Asia-Pacific Historic Review for Corneal Transplants by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 160: Asia-Pacific 15-Year Perspective for Corneal Transplants by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
  • TABLE 161: Asia-Pacific Recent Past, Current & Future Analysis for Corneal Transplants by Procedure Type - Penetrating Keratoplasty, Endothelial Keratoplasty, Descemet Stripping Automated Endothelial Keratoplasty, Corneal Grafts, Corneal Limbal Stem Cell Transplants and Other Procedures - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 162: Asia-Pacific Historic Review for Corneal Transplants by Procedure Type - Penetrating Keratoplasty, Endothelial Keratoplasty, Descemet Stripping Automated Endothelial Keratoplasty, Corneal Grafts, Corneal Limbal Stem Cell Transplants and Other Procedures Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 163: Asia-Pacific 15-Year Perspective for Corneal Transplants by Procedure Type - Percentage Breakdown of Value Sales for Penetrating Keratoplasty, Endothelial Keratoplasty, Descemet Stripping Automated Endothelial Keratoplasty, Corneal Grafts, Corneal Limbal Stem Cell Transplants and Other Procedures for the Years 2015, 2025 & 2030
  • TABLE 164: Asia-Pacific Recent Past, Current & Future Analysis for Corneal Transplants by Indication - Keratitis, Other Indications, Fungal Corneal Ulcer, Bullous Keratopathy and Keratoconus - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 165: Asia-Pacific Historic Review for Corneal Transplants by Indication - Keratitis, Other Indications, Fungal Corneal Ulcer, Bullous Keratopathy and Keratoconus Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 166: Asia-Pacific 15-Year Perspective for Corneal Transplants by Indication - Percentage Breakdown of Value Sales for Keratitis, Other Indications, Fungal Corneal Ulcer, Bullous Keratopathy and Keratoconus for the Years 2015, 2025 & 2030
  • TABLE 167: Asia-Pacific Recent Past, Current & Future Analysis for Corneal Transplants by End-Use - Hospitals, Eye Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 168: Asia-Pacific Historic Review for Corneal Transplants by End-Use - Hospitals, Eye Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 169: Asia-Pacific 15-Year Perspective for Corneal Transplants by End-Use - Percentage Breakdown of Value Sales for Hospitals, Eye Clinics and Other End-Uses for the Years 2015, 2025 & 2030
• AUSTRALIA
  • Corneal Transplants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
  • TABLE 170: Australia Recent Past, Current & Future Analysis for Corneal Transplants by Procedure Type - Penetrating Keratoplasty, Endothelial Keratoplasty, Descemet Stripping Automated Endothelial Keratoplasty, Corneal Grafts, Corneal Limbal Stem Cell Transplants and Other Procedures - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 171: Australia Historic Review for Corneal Transplants by Procedure Type - Penetrating Keratoplasty, Endothelial Keratoplasty, Descemet Stripping Automated Endothelial Keratoplasty, Corneal Grafts, Corneal Limbal Stem Cell Transplants and Other Procedures Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 172: Australia 15-Year Perspective for Corneal Transplants by Procedure Type - Percentage Breakdown of Value Sales for Penetrating Keratoplasty, Endothelial Keratoplasty, Descemet Stripping Automated Endothelial Keratoplasty, Corneal Grafts, Corneal Limbal Stem Cell Transplants and Other Procedures for the Years 2015, 2025 & 2030
  • TABLE 173: Australia Recent Past, Current & Future Analysis for Corneal Transplants by Indication - Keratitis, Other Indications, Fungal Corneal Ulcer, Bullous Keratopathy and Keratoconus - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 174: Australia Historic Review for Corneal Transplants by Indication - Keratitis, Other Indications, Fungal Corneal Ulcer, Bullous Keratopathy and Keratoconus Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 175: Australia 15-Year Perspective for Corneal Transplants by Indication - Percentage Breakdown of Value Sales for Keratitis, Other Indications, Fungal Corneal Ulcer, Bullous Keratopathy and Keratoconus for the Years 2015, 2025 & 2030
  • TABLE 176: Australia Recent Past, Current & Future Analysis for Corneal Transplants by End-Use - Hospitals, Eye Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 177: Australia Historic Review for Corneal Transplants by End-Use - Hospitals, Eye Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 178: Australia 15-Year Perspective for Corneal Transplants by End-Use - Percentage Breakdown of Value Sales for Hospitals, Eye Clinics and Other End-Uses for the Years 2015, 2025 & 2030
• INDIA
  • Corneal Transplants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
  • TABLE 179: India Recent Past, Current & Future Analysis for Corneal Transplants by Procedure Type - Penetrating Keratoplasty, Endothelial Keratoplasty, Descemet Stripping Automated Endothelial Keratoplasty, Corneal Grafts, Corneal Limbal Stem Cell Transplants and Other Procedures - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 180: India Historic Review for Corneal Transplants by Procedure Type - Penetrating Keratoplasty, Endothelial Keratoplasty, Descemet Stripping Automated Endothelial Keratoplasty, Corneal Grafts, Corneal Limbal Stem Cell Transplants and Other Procedures Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 181: India 15-Year Perspective for Corneal Transplants by Procedure Type - Percentage Breakdown of Value Sales for Penetrating Keratoplasty, Endothelial Keratoplasty, Descemet Stripping Automated Endothelial Keratoplasty, Corneal Grafts, Corneal Limbal Stem Cell Transplants and Other Procedures for the Years 2015, 2025 & 2030
  • TABLE 182: India Recent Past, Current & Future Analysis for Corneal Transplants by Indication - Keratitis, Other Indications, Fungal Corneal Ulcer, Bullous Keratopathy and Keratoconus - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 183: India Historic Review for Corneal Transplants by Indication - Keratitis, Other Indications, Fungal Corneal Ulcer, Bullous Keratopathy and Keratoconus Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 184: India 15-Year Perspective for Corneal Transplants by Indication - Percentage Breakdown of Value Sales for Keratitis, Other Indications, Fungal Corneal Ulcer, Bullous Keratopathy and Keratoconus for the Years 2015, 2025 & 2030
  • TABLE 185: India Recent Past, Current & Future Analysis for Corneal Transplants by End-Use - Hospitals, Eye Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 186: India Historic Review for Corneal Transplants by End-Use - Hospitals, Eye Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 187: India 15-Year Perspective for Corneal Transplants by End-Use - Percentage Breakdown of Value Sales for Hospitals, Eye Clinics and Other End-Uses for the Years 2015, 2025 & 2030
• SOUTH KOREA
  • TABLE 188: South Korea Recent Past, Current & Future Analysis for Corneal Transplants by Procedure Type - Penetrating Keratoplasty, Endothelial Keratoplasty, Descemet Stripping Automated Endothelial Keratoplasty, Corneal Grafts, Corneal Limbal Stem Cell Transplants and Other Procedures - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 189: South Korea Historic Review for Corneal Transplants by Procedure Type - Penetrating Keratoplasty, Endothelial Keratoplasty, Descemet Stripping Automated Endothelial Keratoplasty, Corneal Grafts, Corneal Limbal Stem Cell Transplants and Other Procedures Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 190: South Korea 15-Year Perspective for Corneal Transplants by Procedure Type - Percentage Breakdown of Value Sales for Penetrating Keratoplasty, Endothelial Keratoplasty, Descemet Stripping Automated Endothelial Keratoplasty, Corneal Grafts, Corneal Limbal Stem Cell Transplants and Other Procedures for the Years 2015, 2025 & 2030
  • TABLE 191: South Korea Recent Past, Current & Future Analysis for Corneal Transplants by Indication - Keratitis, Other Indications, Fungal Corneal Ulcer, Bullous Keratopathy and Keratoconus - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 192: South Korea Historic Review for Corneal Transplants by Indication - Keratitis, Other Indications, Fungal Corneal Ulcer, Bullous Keratopathy and Keratoconus Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 193: South Korea 15-Year Perspective for Corneal Transplants by Indication - Percentage Breakdown of Value Sales for Keratitis, Other Indications, Fungal Corneal Ulcer, Bullous Keratopathy and Keratoconus for the Years 2015, 2025 & 2030
  • TABLE 194: South Korea Recent Past, Current & Future Analysis for Corneal Transplants by End-Use - Hospitals, Eye Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 195: South Korea Historic Review for Corneal Transplants by End-Use - Hospitals, Eye Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 196: South Korea 15-Year Perspective for Corneal Transplants by End-Use - Percentage Breakdown of Value Sales for Hospitals, Eye Clinics and Other End-Uses for the Years 2015, 2025 & 2030
• REST OF ASIA-PACIFIC
  • TABLE 197: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Corneal Transplants by Procedure Type - Penetrating Keratoplasty, Endothelial Keratoplasty, Descemet Stripping Automated Endothelial Keratoplasty, Corneal Grafts, Corneal Limbal Stem Cell Transplants and Other Procedures - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 198: Rest of Asia-Pacific Historic Review for Corneal Transplants by Procedure Type - Penetrating Keratoplasty, Endothelial Keratoplasty, Descemet Stripping Automated Endothelial Keratoplasty, Corneal Grafts, Corneal Limbal Stem Cell Transplants and Other Procedures Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 199: Rest of Asia-Pacific 15-Year Perspective for Corneal Transplants by Procedure Type - Percentage Breakdown of Value Sales for Penetrating Keratoplasty, Endothelial Keratoplasty, Descemet Stripping Automated Endothelial Keratoplasty, Corneal Grafts, Corneal Limbal Stem Cell Transplants and Other Procedures for the Years 2015, 2025 & 2030
  • TABLE 200: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Corneal Transplants by Indication - Keratitis, Other Indications, Fungal Corneal Ulcer, Bullous Keratopathy and Keratoconus - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 201: Rest of Asia-Pacific Historic Review for Corneal Transplants by Indication - Keratitis, Other Indications, Fungal Corneal Ulcer, Bullous Keratopathy and Keratoconus Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 202: Rest of Asia-Pacific 15-Year Perspective for Corneal Transplants by Indication - Percentage Breakdown of Value Sales for Keratitis, Other Indications, Fungal Corneal Ulcer, Bullous Keratopathy and Keratoconus for the Years 2015, 2025 & 2030
  • TABLE 203: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Corneal Transplants by End-Use - Hospitals, Eye Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 204: Rest of Asia-Pacific Historic Review for Corneal Transplants by End-Use - Hospitals, Eye Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 205: Rest of Asia-Pacific 15-Year Perspective for Corneal Transplants by End-Use - Percentage Breakdown of Value Sales for Hospitals, Eye Clinics and Other End-Uses for the Years 2015, 2025 & 2030
• LATIN AMERICA
  • Corneal Transplants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
  • TABLE 206: Latin America Recent Past, Current & Future Analysis for Corneal Transplants by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 207: Latin America Historic Review for Corneal Transplants by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 208: Latin America 15-Year Perspective for Corneal Transplants by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
  • TABLE 209: Latin America Recent Past, Current & Future Analysis for Corneal Transplants by Procedure Type - Penetrating Keratoplasty, Endothelial Keratoplasty, Descemet Stripping Automated Endothelial Keratoplasty, Corneal Grafts, Corneal Limbal Stem Cell Transplants and Other Procedures - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 210: Latin America Historic Review for Corneal Transplants by Procedure Type - Penetrating Keratoplasty, Endothelial Keratoplasty, Descemet Stripping Automated Endothelial Keratoplasty, Corneal Grafts, Corneal Limbal Stem Cell Transplants and Other Procedures Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 211: Latin America 15-Year Perspective for Corneal Transplants by Procedure Type - Percentage Breakdown of Value Sales for Penetrating Keratoplasty, Endothelial Keratoplasty, Descemet Stripping Automated Endothelial Keratoplasty, Corneal Grafts, Corneal Limbal Stem Cell Transplants and Other Procedures for the Years 2015, 2025 & 2030
  • TABLE 212: Latin America Recent Past, Current & Future Analysis for Corneal Transplants by Indication - Keratitis, Other Indications, Fungal Corneal Ulcer, Bullous Keratopathy and Keratoconus - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 213: Latin America Historic Review for Corneal Transplants by Indication - Keratitis, Other Indications, Fungal Corneal Ulcer, Bullous Keratopathy and Keratoconus Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 214: Latin America 15-Year Perspective for Corneal Transplants by Indication - Percentage Breakdown of Value Sales for Keratitis, Other Indications, Fungal Corneal Ulcer, Bullous Keratopathy and Keratoconus for the Years 2015, 2025 & 2030
  • TABLE 215: Latin America Recent Past, Current & Future Analysis for Corneal Transplants by End-Use - Hospitals, Eye Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 216: Latin America Historic Review for Corneal Transplants by End-Use - Hospitals, Eye Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 217: Latin America 15-Year Perspective for Corneal Transplants by End-Use - Percentage Breakdown of Value Sales for Hospitals, Eye Clinics and Other End-Uses for the Years 2015, 2025 & 2030
• ARGENTINA
  • TABLE 218: Argentina Recent Past, Current & Future Analysis for Corneal Transplants by Procedure Type - Penetrating Keratoplasty, Endothelial Keratoplasty, Descemet Stripping Automated Endothelial Keratoplasty, Corneal Grafts, Corneal Limbal Stem Cell Transplants and Other Procedures - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 219: Argentina Historic Review for Corneal Transplants by Procedure Type - Penetrating Keratoplasty, Endothelial Keratoplasty, Descemet Stripping Automated Endothelial Keratoplasty, Corneal Grafts, Corneal Limbal Stem Cell Transplants and Other Procedures Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 220: Argentina 15-Year Perspective for Corneal Transplants by Procedure Type - Percentage Breakdown of Value Sales for Penetrating Keratoplasty, Endothelial Keratoplasty, Descemet Stripping Automated Endothelial Keratoplasty, Corneal Grafts, Corneal Limbal Stem Cell Transplants and Other Procedures for the Years 2015, 2025 & 2030
  • TABLE 221: Argentina Recent Past, Current & Future Analysis for Corneal Transplants by Indication - Keratitis, Other Indications, Fungal Corneal Ulcer, Bullous Keratopathy and Keratoconus - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 222: Argentina Historic Review for Corneal Transplants by Indication - Keratitis, Other Indications, Fungal Corneal Ulcer, Bullous Keratopathy and Keratoconus Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 223: Argentina 15-Year Perspective for Corneal Transplants by Indication - Percentage Breakdown of Value Sales for Keratitis, Other Indications, Fungal Corneal Ulcer, Bullous Keratopathy and Keratoconus for the Years 2015, 2025 & 2030
  • TABLE 224: Argentina Recent Past, Current & Future Analysis for Corneal Transplants by End-Use - Hospitals, Eye Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 225: Argentina Historic Review for Corneal Transplants by End-Use - Hospitals, Eye Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 226: Argentina 15-Year Perspective for Corneal Transplants by End-Use - Percentage Breakdown of Value Sales for Hospitals, Eye Clinics and Other End-Uses for the Years 2015, 2025 & 2030
• BRAZIL
  • TABLE 227: Brazil Recent Past, Current & Future Analysis for Corneal Transplants by Procedure Type - Penetrating Keratoplasty, Endothelial Keratoplasty, Descemet Stripping Automated Endothelial Keratoplasty, Corneal Grafts, Corneal Limbal Stem Cell Transplants and Other Procedures - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 228: Brazil Historic Review for Corneal Transplants by Procedure Type - Penetrating Keratoplasty, Endothelial Keratoplasty, Descemet Stripping Automated Endothelial Keratoplasty, Corneal Grafts, Corneal Limbal Stem Cell Transplants and Other Procedures Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 229: Brazil 15-Year Perspective for Corneal Transplants by Procedure Type - Percentage Breakdown of Value Sales for Penetrating Keratoplasty, Endothelial Keratoplasty, Descemet Stripping Automated Endothelial Keratoplasty, Corneal Grafts, Corneal Limbal Stem Cell Transplants and Other Procedures for the Years 2015, 2025 & 2030
  • TABLE 230: Brazil Recent Past, Current & Future Analysis for Corneal Transplants by Indication - Keratitis, Other Indications, Fungal Corneal Ulcer, Bullous Keratopathy and Keratoconus - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 231: Brazil Historic Review for Corneal Transplants by Indication - Keratitis, Other Indications, Fungal Corneal Ulcer, Bullous Keratopathy and Keratoconus Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 232: Brazil 15-Year Perspective for Corneal Transplants by Indication - Percentage Breakdown of Value Sales for Keratitis, Other Indications, Fungal Corneal Ulcer, Bullous Keratopathy and Keratoconus for the Years 2015, 2025 & 2030
  • TABLE 233: Brazil Recent Past, Current & Future Analysis for Corneal Transplants by End-Use - Hospitals, Eye Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 234: Brazil Historic Review for Corneal Transplants by End-Use - Hospitals, Eye Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 235: Brazil 15-Year Perspective for Corneal Transplants by End-Use - Percentage Breakdown of Value Sales for Hospitals, Eye Clinics and Other End-Uses for the Years 2015, 2025 & 2030
• MEXICO
  • TABLE 236: Mexico Recent Past, Current & Future Analysis for Corneal Transplants by Procedure Type - Penetrating Keratoplasty, Endothelial Keratoplasty, Descemet Stripping Automated Endothelial Keratoplasty, Corneal Grafts, Corneal Limbal Stem Cell Transplants and Other Procedures - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 237: Mexico Historic Review for Corneal Transplants by Procedure Type - Penetrating Keratoplasty, Endothelial Keratoplasty, Descemet Stripping Automated Endothelial Keratoplasty, Corneal Grafts, Corneal Limbal Stem Cell Transplants and Other Procedures Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 238: Mexico 15-Year Perspective for Corneal Transplants by Procedure Type - Percentage Breakdown of Value Sales for Penetrating Keratoplasty, Endothelial Keratoplasty, Descemet Stripping Automated Endothelial Keratoplasty, Corneal Grafts, Corneal Limbal Stem Cell Transplants and Other Procedures for the Years 2015, 2025 & 2030
  • TABLE 239: Mexico Recent Past, Current & Future Analysis for Corneal Transplants by Indication - Keratitis, Other Indications, Fungal Corneal Ulcer, Bullous Keratopathy and Keratoconus - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 240: Mexico Historic Review for Corneal Transplants by Indication - Keratitis, Other Indications, Fungal Corneal Ulcer, Bullous Keratopathy and Keratoconus Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 241: Mexico 15-Year Perspective for Corneal Transplants by Indication - Percentage Breakdown of Value Sales for Keratitis, Other Indications, Fungal Corneal Ulcer, Bullous Keratopathy and Keratoconus for the Years 2015, 2025 & 2030
  • TABLE 242: Mexico Recent Past, Current & Future Analysis for Corneal Transplants by End-Use - Hospitals, Eye Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 243: Mexico Historic Review for Corneal Transplants by End-Use - Hospitals, Eye Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 244: Mexico 15-Year Perspective for Corneal Transplants by End-Use - Percentage Breakdown of Value Sales for Hospitals, Eye Clinics and Other End-Uses for the Years 2015, 2025 & 2030
• REST OF LATIN AMERICA
  • TABLE 245: Rest of Latin America Recent Past, Current & Future Analysis for Corneal Transplants by Procedure Type - Penetrating Keratoplasty, Endothelial Keratoplasty, Descemet Stripping Automated Endothelial Keratoplasty, Corneal Grafts, Corneal Limbal Stem Cell Transplants and Other Procedures - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 246: Rest of Latin America Historic Review for Corneal Transplants by Procedure Type - Penetrating Keratoplasty, Endothelial Keratoplasty, Descemet Stripping Automated Endothelial Keratoplasty, Corneal Grafts, Corneal Limbal Stem Cell Transplants and Other Procedures Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 247: Rest of Latin America 15-Year Perspective for Corneal Transplants by Procedure Type - Percentage Breakdown of Value Sales for Penetrating Keratoplasty, Endothelial Keratoplasty, Descemet Stripping Automated Endothelial Keratoplasty, Corneal Grafts, Corneal Limbal Stem Cell Transplants and Other Procedures for the Years 2015, 2025 & 2030
  • TABLE 248: Rest of Latin America Recent Past, Current & Future Analysis for Corneal Transplants by Indication - Keratitis, Other Indications, Fungal Corneal Ulcer, Bullous Keratopathy and Keratoconus - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 249: Rest of Latin America Historic Review for Corneal Transplants by Indication - Keratitis, Other Indications, Fungal Corneal Ulcer, Bullous Keratopathy and Keratoconus Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 250: Rest of Latin America 15-Year Perspective for Corneal Transplants by Indication - Percentage Breakdown of Value Sales for Keratitis, Other Indications, Fungal Corneal Ulcer, Bullous Keratopathy and Keratoconus for the Years 2015, 2025 & 2030
  • TABLE 251: Rest of Latin America Recent Past, Current & Future Analysis for Corneal Transplants by End-Use - Hospitals, Eye Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 252: Rest of Latin America Historic Review for Corneal Transplants by End-Use - Hospitals, Eye Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 253: Rest of Latin America 15-Year Perspective for Corneal Transplants by End-Use - Percentage Breakdown of Value Sales for Hospitals, Eye Clinics and Other End-Uses for the Years 2015, 2025 & 2030
• MIDDLE EAST
  • Corneal Transplants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
  • TABLE 254: Middle East Recent Past, Current & Future Analysis for Corneal Transplants by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 255: Middle East Historic Review for Corneal Transplants by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 256: Middle East 15-Year Perspective for Corneal Transplants by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
  • TABLE 257: Middle East Recent Past, Current & Future Analysis for Corneal Transplants by Procedure Type - Penetrating Keratoplasty, Endothelial Keratoplasty, Descemet Stripping Automated Endothelial Keratoplasty, Corneal Grafts, Corneal Limbal Stem Cell Transplants and Other Procedures - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 258: Middle East Historic Review for Corneal Transplants by Procedure Type - Penetrating Keratoplasty, Endothelial Keratoplasty, Descemet Stripping Automated Endothelial Keratoplasty, Corneal Grafts, Corneal Limbal Stem Cell Transplants and Other Procedures Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 259: Middle East 15-Year Perspective for Corneal Transplants by Procedure Type - Percentage Breakdown of Value Sales for Penetrating Keratoplasty, Endothelial Keratoplasty, Descemet Stripping Automated Endothelial Keratoplasty, Corneal Grafts, Corneal Limbal Stem Cell Transplants and Other Procedures for the Years 2015, 2025 & 2030
  • TABLE 260: Middle East Recent Past, Current & Future Analysis for Corneal Transplants by Indication - Keratitis, Other Indications, Fungal Corneal Ulcer, Bullous Keratopathy and Keratoconus - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 261: Middle East Historic Review for Corneal Transplants by Indication - Keratitis, Other Indications, Fungal Corneal Ulcer, Bullous Keratopathy and Keratoconus Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 262: Middle East 15-Year Perspective for Corneal Transplants by Indication - Percentage Breakdown of Value Sales for Keratitis, Other Indications, Fungal Corneal Ulcer, Bullous Keratopathy and Keratoconus for the Years 2015, 2025 & 2030
  • TABLE 263: Middle East Recent Past, Current & Future Analysis for Corneal Transplants by End-Use - Hospitals, Eye Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 264: Middle East Historic Review for Corneal Transplants by End-Use - Hospitals, Eye Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 265: Middle East 15-Year Perspective for Corneal Transplants by End-Use - Percentage Breakdown of Value Sales for Hospitals, Eye Clinics and Other End-Uses for the Years 2015, 2025 & 2030
• IRAN
  • TABLE 266: Iran Recent Past, Current & Future Analysis for Corneal Transplants by Procedure Type - Penetrating Keratoplasty, Endothelial Keratoplasty, Descemet Stripping Automated Endothelial Keratoplasty, Corneal Grafts, Corneal Limbal Stem Cell Transplants and Other Procedures - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 267: Iran Historic Review for Corneal Transplants by Procedure Type - Penetrating Keratoplasty, Endothelial Keratoplasty, Descemet Stripping Automated Endothelial Keratoplasty, Corneal Grafts, Corneal Limbal Stem Cell Transplants and Other Procedures Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 268: Iran 15-Year Perspective for Corneal Transplants by Procedure Type - Percentage Breakdown of Value Sales for Penetrating Keratoplasty, Endothelial Keratoplasty, Descemet Stripping Automated Endothelial Keratoplasty, Corneal Grafts, Corneal Limbal Stem Cell Transplants and Other Procedures for the Years 2015, 2025 & 2030
  • TABLE 269: Iran Recent Past, Current & Future Analysis for Corneal Transplants by Indication - Keratitis, Other Indications, Fungal Corneal Ulcer, Bullous Keratopathy and Keratoconus - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 270: Iran Historic Review for Corneal Transplants by Indication - Keratitis, Other Indications, Fungal Corneal Ulcer, Bullous Keratopathy and Keratoconus Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 271: Iran 15-Year Perspective for Corneal Transplants by Indication - Percentage Breakdown of Value Sales for Keratitis, Other Indications, Fungal Corneal Ulcer, Bullous Keratopathy and Keratoconus for the Years 2015, 2025 & 2030
  • TABLE 272: Iran Recent Past, Current & Future Analysis for Corneal Transplants by End-Use - Hospitals, Eye Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 273: Iran Historic Review for Corneal Transplants by End-Use - Hospitals, Eye Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 274: Iran 15-Year Perspective for Corneal Transplants by End-Use - Percentage Breakdown of Value Sales for Hospitals, Eye Clinics and Other End-Uses for the Years 2015, 2025 & 2030
• ISRAEL
  • TABLE 275: Israel Recent Past, Current & Future Analysis for Corneal Transplants by Procedure Type - Penetrating Keratoplasty, Endothelial Keratoplasty, Descemet Stripping Automated Endothelial Keratoplasty, Corneal Grafts, Corneal Limbal Stem Cell Transplants and Other Procedures - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 276: Israel Historic Review for Corneal Transplants by Procedure Type - Penetrating Keratoplasty, Endothelial Keratoplasty, Descemet Stripping Automated Endothelial Keratoplasty, Corneal Grafts, Corneal Limbal Stem Cell Transplants and Other Procedures Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 277: Israel 15-Year Perspective for Corneal Transplants by Procedure Type - Percentage Breakdown of Value Sales for Penetrating Keratoplasty, Endothelial Keratoplasty, Descemet Stripping Automated Endothelial Keratoplasty, Corneal Grafts, Corneal Limbal Stem Cell Transplants and Other Procedures for the Years 2015, 2025 & 2030
  • TABLE 278: Israel Recent Past, Current & Future Analysis for Corneal Transplants by Indication - Keratitis, Other Indications, Fungal Corneal Ulcer, Bullous Keratopathy and Keratoconus - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 279: Israel Historic Review for Corneal Transplants by Indication - Keratitis, Other Indications, Fungal Corneal Ulcer, Bullous Keratopathy and Keratoconus Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 280: Israel 15-Year Perspective for Corneal Transplants by Indication - Percentage Breakdown of Value Sales for Keratitis, Other Indications, Fungal Corneal Ulcer, Bullous Keratopathy and Keratoconus for the Years 2015, 2025 & 2030
  • TABLE 281: Israel Recent Past, Current & Future Analysis for Corneal Transplants by End-Use - Hospitals, Eye Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 282: Israel Historic Review for Corneal Transplants by End-Use - Hospitals, Eye Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 283: Israel 15-Year Perspective for Corneal Transplants by End-Use - Percentage Breakdown of Value Sales for Hospitals, Eye Clinics and Other End-Uses for the Years 2015, 2025 & 2030
• SAUDI ARABIA
  • TABLE 284: Saudi Arabia Recent Past, Current & Future Analysis for Corneal Transplants by Procedure Type - Penetrating Keratoplasty, Endothelial Keratoplasty, Descemet Stripping Automated Endothelial Keratoplasty, Corneal Grafts, Corneal Limbal Stem Cell Transplants and Other Procedures - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 285: Saudi Arabia Historic Review for Corneal Transplants by Procedure Type - Penetrating Keratoplasty, Endothelial Keratoplasty, Descemet Stripping Automated Endothelial Keratoplasty, Corneal Grafts, Corneal Limbal Stem Cell Transplants and Other Procedures Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 286: Saudi Arabia 15-Year Perspective for Corneal Transplants by Procedure Type - Percentage Breakdown of Value Sales for Penetrating Keratoplasty, Endothelial Keratoplasty, Descemet Stripping Automated Endothelial Keratoplasty, Corneal Grafts, Corneal Limbal Stem Cell Transplants and Other Procedures for the Years 2015, 2025 & 2030
  • TABLE 287: Saudi Arabia Recent Past, Current & Future Analysis for Corneal Transplants by Indication - Keratitis, Other Indications, Fungal Corneal Ulcer, Bullous Keratopathy and Keratoconus - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 288: Saudi Arabia Historic Review for Corneal Transplants by Indication - Keratitis, Other Indications, Fungal Corneal Ulcer, Bullous Keratopathy and Keratoconus Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 289: Saudi Arabia 15-Year Perspective for Corneal Transplants by Indication - Percentage Breakdown of Value Sales for Keratitis, Other Indications, Fungal Corneal Ulcer, Bullous Keratopathy and Keratoconus for the Years 2015, 2025 & 2030
  • TABLE 290: Saudi Arabia Recent Past, Current & Future Analysis for Corneal Transplants by End-Use - Hospitals, Eye Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 291: Saudi Arabia Historic Review for Corneal Transplants by End-Use - Hospitals, Eye Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 292: Saudi Arabia 15-Year Perspective for Corneal Transplants by End-Use - Percentage Breakdown of Value Sales for Hospitals, Eye Clinics and Other End-Uses for the Years 2015, 2025 & 2030
• UNITED ARAB EMIRATES
  • TABLE 293: UAE Recent Past, Current & Future Analysis for Corneal Transplants by Procedure Type - Penetrating Keratoplasty, Endothelial Keratoplasty, Descemet Stripping Automated Endothelial Keratoplasty, Corneal Grafts, Corneal Limbal Stem Cell Transplants and Other Procedures - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 294: UAE Historic Review for Corneal Transplants by Procedure Type - Penetrating Keratoplasty, Endothelial Keratoplasty, Descemet Stripping Automated Endothelial Keratoplasty, Corneal Grafts, Corneal Limbal Stem Cell Transplants and Other Procedures Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 295: UAE 15-Year Perspective for Corneal Transplants by Procedure Type - Percentage Breakdown of Value Sales for Penetrating Keratoplasty, Endothelial Keratoplasty, Descemet Stripping Automated Endothelial Keratoplasty, Corneal Grafts, Corneal Limbal Stem Cell Transplants and Other Procedures for the Years 2015, 2025 & 2030
  • TABLE 296: UAE Recent Past, Current & Future Analysis for Corneal Transplants by Indication - Keratitis, Other Indications, Fungal Corneal Ulcer, Bullous Keratopathy and Keratoconus - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 297: UAE Historic Review for Corneal Transplants by Indication - Keratitis, Other Indications, Fungal Corneal Ulcer, Bullous Keratopathy and Keratoconus Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 298: UAE 15-Year Perspective for Corneal Transplants by Indication - Percentage Breakdown of Value Sales for Keratitis, Other Indications, Fungal Corneal Ulcer, Bullous Keratopathy and Keratoconus for the Years 2015, 2025 & 2030
  • TABLE 299: UAE Recent Past, Current & Future Analysis for Corneal Transplants by End-Use - Hospitals, Eye Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 300: UAE Historic Review for Corneal Transplants by End-Use - Hospitals, Eye Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 301: UAE 15-Year Perspective for Corneal Transplants by End-Use - Percentage Breakdown of Value Sales for Hospitals, Eye Clinics and Other End-Uses for the Years 2015, 2025 & 2030
• REST OF MIDDLE EAST
  • TABLE 302: Rest of Middle East Recent Past, Current & Future Analysis for Corneal Transplants by Procedure Type - Penetrating Keratoplasty, Endothelial Keratoplasty, Descemet Stripping Automated Endothelial Keratoplasty, Corneal Grafts, Corneal Limbal Stem Cell Transplants and Other Procedures - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 303: Rest of Middle East Historic Review for Corneal Transplants by Procedure Type - Penetrating Keratoplasty, Endothelial Keratoplasty, Descemet Stripping Automated Endothelial Keratoplasty, Corneal Grafts, Corneal Limbal Stem Cell Transplants and Other Procedures Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 304: Rest of Middle East 15-Year Perspective for Corneal Transplants by Procedure Type - Percentage Breakdown of Value Sales for Penetrating Keratoplasty, Endothelial Keratoplasty, Descemet Stripping Automated Endothelial Keratoplasty, Corneal Grafts, Corneal Limbal Stem Cell Transplants and Other Procedures for the Years 2015, 2025 & 2030
  • TABLE 305: Rest of Middle East Recent Past, Current & Future Analysis for Corneal Transplants by Indication - Keratitis, Other Indications, Fungal Corneal Ulcer, Bullous Keratopathy and Keratoconus - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 306: Rest of Middle East Historic Review for Corneal Transplants by Indication - Keratitis, Other Indications, Fungal Corneal Ulcer, Bullous Keratopathy and Keratoconus Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 307: Rest of Middle East 15-Year Perspective for Corneal Transplants by Indication - Percentage Breakdown of Value Sales for Keratitis, Other Indications, Fungal Corneal Ulcer, Bullous Keratopathy and Keratoconus for the Years 2015, 2025 & 2030
  • TABLE 308: Rest of Middle East Recent Past, Current & Future Analysis for Corneal Transplants by End-Use - Hospitals, Eye Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 309: Rest of Middle East Historic Review for Corneal Transplants by End-Use - Hospitals, Eye Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 310: Rest of Middle East 15-Year Perspective for Corneal Transplants by End-Use - Percentage Breakdown of Value Sales for Hospitals, Eye Clinics and Other End-Uses for the Years 2015, 2025 & 2030
• AFRICA
  • Corneal Transplants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
  • TABLE 311: Africa Recent Past, Current & Future Analysis for Corneal Transplants by Procedure Type - Penetrating Keratoplasty, Endothelial Keratoplasty, Descemet Stripping Automated Endothelial Keratoplasty, Corneal Grafts, Corneal Limbal Stem Cell Transplants and Other Procedures - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 312: Africa Historic Review for Corneal Transplants by Procedure Type - Penetrating Keratoplasty, Endothelial Keratoplasty, Descemet Stripping Automated Endothelial Keratoplasty, Corneal Grafts, Corneal Limbal Stem Cell Transplants and Other Procedures Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 313: Africa 15-Year Perspective for Corneal Transplants by Procedure Type - Percentage Breakdown of Value Sales for Penetrating Keratoplasty, Endothelial Keratoplasty, Descemet Stripping Automated Endothelial Keratoplasty, Corneal Grafts, Corneal Limbal Stem Cell Transplants and Other Procedures for the Years 2015, 2025 & 2030
  • TABLE 314: Africa Recent Past, Current & Future Analysis for Corneal Transplants by Indication - Keratitis, Other Indications, Fungal Corneal Ulcer, Bullous Keratopathy and Keratoconus - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 315: Africa Historic Review for Corneal Transplants by Indication - Keratitis, Other Indications, Fungal Corneal Ulcer, Bullous Keratopathy and Keratoconus Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 316: Africa 15-Year Perspective for Corneal Transplants by Indication - Percentage Breakdown of Value Sales for Keratitis, Other Indications, Fungal Corneal Ulcer, Bullous Keratopathy and Keratoconus for the Years 2015, 2025 & 2030
  • TABLE 317: Africa Recent Past, Current & Future Analysis for Corneal Transplants by End-Use - Hospitals, Eye Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 318: Africa Historic Review for Corneal Transplants by End-Use - Hospitals, Eye Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 319: Africa 15-Year Perspective for Corneal Transplants by End-Use - Percentage Breakdown of Value Sales for Hospitals, Eye Clinics and Other End-Uses for the Years 2015, 2025 & 2030

IV. COMPETITION